Special Issue: The Trend in Molecular Diagnosis of Respiratory Diseases and their Immunity
Prof. Dr. Karima Alsalihi, Ph.D.
in Pathology from University of Baghdad. Editor in Chief of MRVSA Journal
Prof. Dr. Mohenned Alsaadawi, Ph.D.
in Infection, Immunity and Inflammation from University of Leicester, UK
In humans and animals, respiratory infections (RIs) are one of the leading causes of morbidity and mortality. RIs are responsible for millions of deaths each year over the world and cause a significant financial loss on all countries' health and veterinary services. Pathogens such as viruses, bacteria, and other dangerous microbes can be the causes of RIs. Many pathogens and opportunistic microorganisms are implicated in the etiology of respiratory tract infections, making precise diagnosis difficult. Technology advancements and fresh approaches for producing rapid diagnostic tests and biomarkers for RIs are critical challenges in the treatment of RIs. Without a proper diagnosis of the causative germ and their antibiotic sensitivity patterns, infected people who appear with any type of RIs are always treated empirically. Acute and chronic bacterial and viral illnesses require difficult and time-consuming diagnostic testing. Because RIs have such high morbidity and mortality rates, the detection of pathogenic causes of RIs still crucial.
In order to detect respiratory tract infections, there are numerous multiparametric molecular diagnostics tests available. In addition, we have been informed that the dependability of the molecular drug resistance markers used, the requirement for quantitative detection of particular organisms, and the amount are all critical considerations for new technology development. In parallel with the development of new diagnostic technologies for health care, a multitude of biomarkers of disease activity will become available for use in monitoring treatment efficacy and cure. The use of modern technologies in the detection of respiratory disorders is becoming increasingly popular. The development of biomarker tools within the scope of the project is also needed in order for them to be made available within the next ten years. It has the potential to modernize the control of respiratory tract infections, resulting in a reduction in mortality and morbidity around the world. Researchers are encouraged to submit systematic reviews, and original research manuscripts that deal with the current trends in the diagnosis of respiratory diseases and that contribute to the investigation of immunity-related to various causes of respiratory germs.
With this we invite manuscript submissions into the following topics:
• The importance of rapid, early, and specific diagnosis of RIs is great in reducing morbidity and mortality.
• It is possible to detect antigens and antibodies directly from samples using modern immunological diagnostic techniques, which are becoming increasingly popular.
• Diagnostic approaches based on improved immunohistochemistry techniques are useful in the detection of RIs.
• Molecular diagnostic assays and microsatellites are routinely used to aid in the identification of infectious diseases.
• Molecular epidemiological studies that are performed quickly can aid in the early diagnosis of RIs, allowing for more rapid treatment and control of the disease.
• A phylogenetic analysis was carried out to determine the links between RIs germs and previously documented genotypes recorded in the GenBank repository.
• The advancements made in the diagnosis of common infectious respiratory diseases, such as bronchitis and pneumonia.
• Assisting with adapting and implementing suitable, timely, and confirmatory diagnostic techniques by providing knowledge updates.
• Developing proper prevention procedures and control strategies to combat respiratory infections.
Instruction for Authors
Please submit your manuscript to online submission system